ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019
08/06/19
ReWalk Robotics Announces Closing of Registered Direct Offering for $5.0 Million Priced At-the-Market
06/12/19
ReWalk Robotics Announces Exercise of Warrants Resulting in Cash Proceeds of $10.8 Million
06/05/19
FDA Issues Clearance for the ReStore™ Exo-Suit, the First Soft Robotic System for Stroke Therapy
06/04/19
ReWalk Robotics Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device
05/29/19
ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again
04/25/19
Displaying 121 - 132 of 280